| |
| |
|
| Insider
Information: |
Ang Robert |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,089,893 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$793,851 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,089,893 |
|
|
| Total
Value |
$793,851 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neon Therapeutics, Inc. |
NTGN |
Chief Business Officer |
2019-02-27 |
279,525 |
2019-02-27 |
0 |
Premium* |
|
|
Vor Biopharma Inc. |
VOR |
|
2024-05-06 |
810,368 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VOR |
Vor Biopharma Inc. |
PRESIDENT AND CEO |
• • – |
2024-05-06 |
4 |
D |
$1.75 |
$4,132 |
D/D |
(2,361) |
810,368 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
PRESIDENT AND CEO |
• • – |
2024-05-01 |
4 |
D |
$1.77 |
$4,869 |
D/D |
(2,751) |
812,729 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
PRESIDENT AND CEO |
• • – |
2024-03-01 |
4 |
D |
$2.27 |
$28,731 |
D/D |
(12,657) |
815,480 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
PRESIDENT AND CEO |
• • – |
2024-02-06 |
4 |
D |
$2.32 |
$6,468 |
D/D |
(2,788) |
828,137 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
PRESIDENT AND CEO |
• • – |
2024-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
830,925 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
President and CEO |
• • – |
2023-11-06 |
4 |
D |
$1.82 |
$4,297 |
D/D |
(2,361) |
680,925 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
President and CEO |
• • – |
2023-09-01 |
4 |
D |
$2.67 |
$33,794 |
D/D |
(12,657) |
683,286 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
President and CEO |
• • – |
2023-08-07 |
4 |
D |
$2.67 |
$6,304 |
D/D |
(2,361) |
695,943 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
President and CEO |
• • – |
2023-05-08 |
4 |
D |
$4.14 |
$9,775 |
D/D |
(2,361) |
698,304 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
President and CEO |
• • – |
2023-03-01 |
4 |
D |
$5.51 |
$69,740 |
D/D |
(12,657) |
700,665 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
President and CEO |
• • – |
2023-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
128,750 |
713,322 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
President and CEO |
• • – |
2022-09-13 |
4 |
A |
$0.00 |
$0 |
D/D |
172,500 |
584,572 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
President and CEOOfficer |
• • – |
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
412,072 |
|
- |
|
| NTGN |
Neon Therapeutics, Inc. |
Chief Business Officer |
• – – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
279,525 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
